Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 151

1.

Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.

Martin-Malo A, Borchard G, Flühmann B, Mori C, Silverberg D, Jankowska EA.

ESC Heart Fail. 2019 Jan 29. doi: 10.1002/ehf2.12400. [Epub ahead of print] Review.

PMID:
30694615
2.

Pharmacological interactions of phosphate binders.

Bover Sanjuán J, Navarro-González JF, Arenas MD, Torregrosa JV, Tamargo Menéndez J, de Francisco ALM, González-Parra E, Lloret Cora MJ, Sánchez Álvarez JE, Martín-Malo A, Molina Vila P, Bajo MA, DaSilva Santos I.

Nefrologia. 2018 Nov - Dec;38(6):573-578. doi: 10.1016/j.nefro.2018.05.003. Epub 2018 Jul 7. English, Spanish. No abstract available.

3.

Increased Phosphaturia Accelerates The Decline in Renal Function: A Search for Mechanisms.

Santamaría R, Díaz-Tocados JM, Pendón-Ruiz de Mier MV, Robles A, Salmerón-Rodríguez MD, Ruiz E, Vergara N, Aguilera-Tejero E, Raya A, Ortega R, Felsenfeld A, Muñoz-Castañeda JR, Martín-Malo A, Aljama P, Rodríguez M.

Sci Rep. 2018 Sep 12;8(1):13701. doi: 10.1038/s41598-018-32065-2.

4.

Phosphate control in reducing FGF23 levels in hemodialysis patients.

Rodelo-Haad C, Rodríguez-Ortiz ME, Martin-Malo A, Pendon-Ruiz de Mier MV, Agüera ML, Muñoz-Castañeda JR, Soriano S, Caravaca F, Alvarez-Lara MA, Felsenfeld A, Aljama P, Rodriguez M.

PLoS One. 2018 Aug 7;13(8):e0201537. doi: 10.1371/journal.pone.0201537. eCollection 2018.

5.

Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis.

Pérez-García R, Varas J, Cives A, Martín-Malo A, Aljama P, Ramos R, Pascual J, Stuard S, Canaud B, Merello JI; ORD group.

Nephrol Dial Transplant. 2018 Jan 1;33(1):187. doi: 10.1093/ndt/gfx315. No abstract available.

PMID:
29077898
6.

Hemodiafiltration Reduces All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients: A Propensity-Matched Cohort Study.

Maduell F, Varas J, Ramos R, Martin-Malo A, Pérez-Garcia R, Berdud I, Moreso F, Canaud B, Stuard S, Gauly A, Aljama P, Merello JI.

Am J Nephrol. 2017;46(4):288-297. doi: 10.1159/000481669. Epub 2017 Oct 17.

PMID:
29041011
7.

Increased mortality in haemodialysis patients administered high doses of erythropoiesis-stimulating agents: a propensity score-matched analysis.

Pérez-García R, Varas J, Cives A, Martín-Malo A, Aljama P, Ramos R, Pascual J, Stuard S, Canaud B, Merello JI; ORD group.

Nephrol Dial Transplant. 2018 Apr 1;33(4):690-699. doi: 10.1093/ndt/gfx269.

PMID:
29036505
8.

Relationships between iron dose, hospitalizations and mortality in incident haemodialysis patients: a propensity-score matched approach.

Varas J, Ramos R, Aljama P, Pérez-García R, Moreso F, Pinedo M, Ignacio Merello J, Stuard S, Canaud B, Martín-Malo A; ORD Group.

Nephrol Dial Transplant. 2018 Jan 1;33(1):160-170. doi: 10.1093/ndt/gfx209.

PMID:
28992120
9.

Correction of 25-OH-vitamin D deficiency improves control of secondary hyperparathyroidism and reduces the inflammation in stable haemodialysis patients.

Ojeda López R, Esquivias de Motta E, Carmona A, García Montemayor V, Berdud I, Martín Malo A, Aljama García P.

Nefrologia. 2018 Jan - Feb;38(1):41-47. doi: 10.1016/j.nefro.2017.05.008. Epub 2017 Jul 1. English, Spanish.

10.

Markers of endothelial damage in patients with chronic kidney disease on hemodialysis.

Carmona A, Agüera ML, Luna-Ruiz C, Buendía P, Calleros L, García-Jerez A, Rodríguez-Puyol M, Arias M, Arias-Guillen M, de Arriba G, Ballarin J, Bernis C, Fernández E, García-Rebollo S, Mancha J, Del Peso G, Pérez E, Poch E, Portolés JM, Rodríguez-Puyol D, Sánchez-Villanueva R, Sarro F, Torres A, Martín-Malo A, Aljama P, Ramírez R, Carracedo J.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F673-F681. doi: 10.1152/ajprenal.00013.2016. Epub 2017 Jan 11. Erratum in: Am J Physiol Renal Physiol. 2018 Jan 1;314(1):F141.

11.

Hemodialysis patients receiving a greater Kt dose than recommended have reduced mortality and hospitalization risk.

Maduell F, Ramos R, Varas J, Martin-Malo A, Molina M, Pérez-Garcia R, Marcelli D, Moreso F, Aljama P, Merello JI.

Kidney Int. 2016 Dec;90(6):1332-1341. doi: 10.1016/j.kint.2016.08.022. Epub 2016 Oct 22.

12.

Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis.

Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F.

Clinicoecon Outcomes Res. 2016 Sep 22;8:531-540. eCollection 2016.

13.

Hemodiafiltration With Endogenous Reinfusion Improved Microinflammation and Endothelial Damage Compared With Online-Hemodiafiltration: A Hypothesis Generating Study.

Esquivias-Motta E, Martín-Malo A, Buendia P, Álvarez-Lara MA, Soriano S, Crespo R, Carracedo J, Ramírez R, Aljama P.

Artif Organs. 2017 Jan;41(1):88-98. doi: 10.1111/aor.12704. Epub 2016 May 16.

PMID:
27182679
14.

A New Data Analysis System to Quantify Associations between Biochemical Parameters of Chronic Kidney Disease-Mineral Bone Disease.

Rodriguez M, Salmeron MD, Martin-Malo A, Barbieri C, Mari F, Molina RI, Costa P, Aljama P.

PLoS One. 2016 Jan 25;11(1):e0146801. doi: 10.1371/journal.pone.0146801. eCollection 2016.

15.

Efficiency of Original versus Generic Intravenous Iron Formulations in Patients on Haemodialysis.

Agüera ML, Martin-Malo A, Alvarez-Lara MA, Garcia-Montemayor VE, Canton P, Soriano S, Aljama P.

PLoS One. 2015 Aug 31;10(8):e0135967. doi: 10.1371/journal.pone.0135967. eCollection 2015.

16.

Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates.

Cantisán S, Rodelo-Haad C, Páez-Vega A, Nieto A, Vaquero JM, Poyato A, Montejo M, Fariñas MC, Rivero A, Solana R, Martín-Malo A, Torre-Cisneros J.

Am J Transplant. 2015 Mar;15(3):715-22. doi: 10.1111/ajt.13012. Epub 2015 Feb 3.

17.

Hypersensitivity reactions to synthetic haemodialysis membranes — an emerging issue?

Alvarez-de Lara MA, Martín-Malo A.

Nefrologia. 2014 Nov 17;34(6):698-702. doi: 10.3265/Nefrologia.pre2014.Jul.12682. English, Spanish. No abstract available.

18.

Endothelial microparticles mediate inflammation-induced vascular calcification.

Buendía P, Montes de Oca A, Madueño JA, Merino A, Martín-Malo A, Aljama P, Ramírez R, Rodríguez M, Carracedo J.

FASEB J. 2015 Jan;29(1):173-81. doi: 10.1096/fj.14-249706. Epub 2014 Oct 23.

PMID:
25342130
19.

Endothelial damage and vascular calcification in patients with chronic kidney disease.

Soriano S, Carmona A, Triviño F, Rodriguez M, Alvarez-Benito M, Martín-Malo A, Alvarez-Lara MA, Ramírez R, Aljama P, Carracedo J.

Am J Physiol Renal Physiol. 2014 Dec 1;307(11):F1302-11. doi: 10.1152/ajprenal.00114.2014. Epub 2014 Oct 22.

20.

Klotho Prevents NFκB Translocation and Protects Endothelial Cell From Senescence Induced by Uremia.

Buendía P, Carracedo J, Soriano S, Madueño JA, Ortiz A, Martín-Malo A, Aljama P, Ramírez R.

J Gerontol A Biol Sci Med Sci. 2015 Oct;70(10):1198-209. doi: 10.1093/gerona/glu170. Epub 2014 Sep 22.

PMID:
25246106

Supplemental Content

Loading ...
Support Center